Tolvaptan

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Tolvaptan and local guidelines before prescribing.

Vasopressin antagonist

Mechanism

Vasopressin V2 antagonist (aquaretic).

Uses

SIADH hyponatraemia (specialist), ADPKD.

Dosing

Side effects

Thirst, polyuria, hepatotoxicity, rapid sodium correction risk.

Interactions

CYP3A4 inhibitors; diuretics.

Contraindications and cautions

Hypovolaemia, hypernatraemia, liver disease

Monitoring

Sodium, LFT

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

Avoid in severe hepatic impairment

Overdose and reversal

Supportive

Special advice

Do not correct sodium faster than 8–10 mmol/L per day; hospital initiation.

More from the textbook: uses, cautions and other points
Where it is discussed in the book